DANAHER CORPORATION vs KLA Corporation, two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where DHR and KLAC diverge most: on ev/ebitda, DHR reads 23.2 and KLAC reads 1098.4; on p/b, DHR reads 2.96 and KLAC reads 40.59. The rest of the comparable metrics sit closer together. What DHR's price implies is a bet that sits within the historical range (whole-company basis). What KLAC's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | DHR | KLAC |
|---|---|---|
| Price | $219.80 | $195.64 |
| Market cap | $155.5B | $257.8B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Mature | Mature |
| Implied growth (priced in) | +23.2% | — |
| P/E | 39.0 | 17.1 |
| P/B | 2.96 | 40.59 |
| P/S | 6.19 | 18.98 |
| EV/EBITDA | 23.2 | 1098.4 |
| Revenue growth | +4.5% | +11.7% |
| Gross margin | 57.6% | — |
| Operating margin | 18.0% | — |
| Net margin | 15.9% | 35.6% |
| Return on equity | 7.6% | 76.1% |
| Return on assets | 4.3% | 26.9% |
| Return on invested capital | 5.2% | — |
| FCF yield | 3.5% | 1.5% |
| Dividend yield | — | 0.4% |
| Debt / equity | 0.50 | 0.93 |
| Current ratio | 1.65 | 2.88 |
| Altman Z (solvency) | 7.11 | 7.58 |
| Piotroski F (quality) | 5 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.